tiprankstipranks
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM

Adverum Biotechnologies (ADVM) Financial Statements

554 Followers

Adverum Biotechnologies Financial Overview

Adverum Biotechnologies's market cap is currently ―. The company's EPS TTM is $-10.23; its P/E ratio is -0.70; Adverum Biotechnologies is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-1.45. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue----$ 3.60M
Gross Profit---$ 1.40M$ 3.60M
EBIT$ -24.83M$ -24.85M$ -32.87M$ -31.49M$ -29.04M
EBITDA$ -23.66M$ -23.38M$ -25.99M$ -25.16M$ -26.98M
Net Income Common Stockholders$ -24.79M$ -24.72M$ -32.82M$ -31.51M$ -29.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 193.33M$ 96.53M$ 117.08M$ 141.45M$ 164.28M
Total Assets$ 267.83M$ 173.01M$ 196.77M$ 241.43M$ 275.58M
Total Debt$ 74.48M$ 75.04M$ 75.52M$ 91.15M$ 97.61M
Net Debt$ -118.84M$ -21.49M$ -41.56M$ -50.30M$ -66.67M
Total Liabilities$ 85.54M$ 89.54M$ 94.06M$ 110.27M$ 117.82M
Stockholders Equity$ 182.29M$ 83.47M$ 102.71M$ 131.13M$ 157.76M
Cash Flow-
Free Cash Flow$ -23.34M$ -21.52M$ -24.41M$ -23.29M$ 2.50M
Operating Cash Flow$ -23.25M$ -21.33M$ -23.91M$ -23.25M$ 2.50M
Investing Cash Flow$ -22.03M$ -9.88M$ 18.20M$ 67.02M$ 21.53M
Financing Cash Flow$ 119.88M$ 166.00K$ -105.00K$ 8.00K-
Currency in USD

Adverum Biotechnologies Earnings and Revenue History

Adverum Biotechnologies Debt to Assets

Adverum Biotechnologies Cash Flow

Adverum Biotechnologies Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis